L. Farrugia

发表

Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial

S. Johnston, A. Lindblad, B. Cucchiara, 2020, Stroke.

Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes.

C. Cobelli, M. Camilleri, R. Rizza, 2015, The Journal of nutrition.

Measuring B-cell function in vivo to understand the pathophysiology of type 2 diabetes

A. Vella, L. Farrugia, 2015 .

RNF213 variation, a broader role in neurovascular disease in Caucasian and Japanese populations

W. Freeman, P. Blackburn, E. Klee, 2020, bioRxiv.

Genetic and clinical heterogeneity of Moyamoya disease

L. Farrugia, 2017 .

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects

C. Cobelli, A. Zinsmeister, R. Rizza, 2013, Diabetes.

X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.

Michael T. Zimmermann, D. Dickson, M. Zimmermann, 2019, Journal of neuropathology and experimental neurology.

Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement

L. Farrugia, K. Khalsa, L. Melia, 2021, Medical mycology case reports.

Case Report: Opsoclonus-Myoclonus Syndrome Associated With Contactin-Associated Protein-Like 2 and Acetylcholine Receptor Autoantibodies in the Setting of Non-Small Cell Lung Carcinoma

Amit Kumar Sharma, L. Farrugia, A. McKeon, 2022 .

Case Report: Opsoclonus-Myoclonus Syndrome Associated With Contactin-Associated Protein-Like 2 and Acetylcholine Receptor Autoantibodies in the Setting of Non-Small Cell Lung Carcinoma.

L. Farrugia, A. McKeon, Akanksha Sharma, 2021, The Neurohospitalist.

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects

C. Cobelli, A. Zinsmeister, R. Rizza, 2013, Diabetes.